{"resourceType":"ValueSet","id":"detectedissue-category","meta":{"lastUpdated":"2019-11-01T09:29:23.356+11:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-wg","valueCode":"cds"}],"url":"http://hl7.org/fhir/ValueSet/detectedissue-category","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.4.642.3.204"}],"version":"4.0.1","name":"DetectedIssueCategory","title":"Detected Issue Category","status":"draft","experimental":false,"date":"2019-11-01T09:29:23+11:00","publisher":"FHIR Project team","contact":[{"telecom":[{"system":"url","value":"http://hl7.org/fhir"}]}],"description":"Kinds of issues or contraindications, such as 'drug-drug interaction', 'duplicate therapy', etc.","compose":{"include":[{"system":"http://terminology.hl7.org/CodeSystem/v3-ActCode","filter":[{"property":"concept","op":"is-a","value":"_AdministrationDetectedIssueCode"}]},{"system":"http://terminology.hl7.org/CodeSystem/v3-ActCode","filter":[{"property":"concept","op":"is-a","value":"_ActSuppliedItemDetectedIssueCode"}]},{"system":"http://terminology.hl7.org/CodeSystem/v3-ActCode","filter":[{"property":"concept","op":"is-a","value":"_SupplyDetectedIssueCode"}]}]}}